About Janux Therapeutics, Inc. 
Janux Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 58 Schemes (31.15%)
Foreign Institutions
Held by 129 Foreign Institutions (12.82%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Mar 2026)
Net Profit:
-24 Million
Pharmaceuticals & Biotechnology
USD 808 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-1.01
-11.88%
0.84






